PST13-RK
General Information
DRACP ID DRACP00200
Peptide Name PST13-RK
Sequence KKKFPWWWPFKKK
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Derivative of tritrpticin
Type Native peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
A549 | Lung adenocarcinoma | Carcinoma | IC50=90 µg/ml | MTT assay | Not available | 1 |
MDA-MB-361 | Breast adenocarcinoma | Carcinoma | IC50=80 µg/ml | MTT assay | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity NIH-3T3 (mouse): IC50=83 µg/ml
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C97H136N22O14
Absent amino acids ACDEGHILMNQRSTVY
Common amino acids K
Mass 204849
Pl 11.5
Basic residues 6
Acidic residues 0
Hydrophobic residues 5
Net charge 6
Boman Index -2035
Hydrophobicity -182.31
Aliphatic Index 0
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 16500
Absorbance 280nm 1375
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 18815734
Title Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity
Year 2009
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available